alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT
      32.1


**CERTIFICATION
        PURSUANT TO**
 **18
        U.S.C. SECTION 1350,**
 **AS
        ADOPTED PURSUANT TO**
 **SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002**
  In
        connection
        with the Quarterly Report of Sangui BioTech International, Inc. (the “Company”)
        on Form 10-QSB for the period ending September 30, 2005 as filed with the
        Securities and Exchange Commission on the date hereof (the “Report”), I,
        Wolfgang Barnikol, Chief Executive Officer and Chief Financial Officer of
        the
        Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to
§ 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge
        and belief:
  (1)        The
        Report fully complies with the requirements of section 13(a) or 15(d) of
        the Securities Exchange Act of 1934; and
  (2)        The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and result of operations of the Company.
   Date:
              September 13,
              2007                             /s/  Wolfgang
              Barnikol
 By:
            Wolfgang Barnikol
 Chief
            Executive Officer and Chief Financial Officer
   A
        signed
        original of this written statement required by Section 906, or other document
        authenticating, acknowledging, or otherwise adopting the signature that appears
        in typed form within the electronic version of this written statement has
        been
        provided to the Company and will be retained by the Company and furnished
        to the
        Securities and Exchange Commission or its staff upon request.
1

Filed 9/23/24 P. v. Nakooka CA3 NOT TO BE PUBLISHED

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

THIRD APPELLATE DISTRICT

(San Joaquin)

----

THE PEOPLE,

Plaintiff and Respondent,

v.

CHARLES NAKOOKA,

Defendant and Appellant. C099612

(Super. Ct. No s

. STKCRFE20040006884 & SF091043A )

Appointed counsel for defendant Charles Nakook a asks this court to review the

record from his postjudgment order and determine whether there are any arguable issues

on appeal. ( People v. Wende (1979) 25 Cal.3d 436.) We exercise our discretion to do so

but find no arguable error that would result in a disposition more favorable to defendant

.

We affirm.

BACKGROUND

In 2004, defendant pled guilty to voluntary manslaughter and attempted murder.

He admitted to using a gun during the se offenses and to committing the voluntary2

manslaughter for the benefit of a street gang. The trial court sentenced defendant to 28

years 8 months in prison

. In 2022, defendant filed a petition for resentencing under Penal Code sec tion

formerly 1170.95 (now section 1172.6). (See People v. Reyes (2023) 14 Cal.5th 981,

984

. ) The trial court appointed counsel, received briefing, and issued an order to show

cause.

At the evidentiary hearing, over defendant’s objection, the trial court considered

the preliminary hearing transcript as well as the parole transcript , both submitted by the

prosecutor. The transcripts showed that during the early evening of February 7, 2004,

witnesses saw a fight between s ome young men. One of those young men fired shots at

the victim . Two of the witnesses identified defendant as the shooter. At his parole

hearing, defendant acknowledged he shot the victim but said it was in self

- defen se.

The trial court concluded the evidence showed beyond a reasonable doubt that

defendant was the actual killer. The court thus found defendant was not eligible for relief

and denied the petition.

Defendant filed a timely notice of appeal.

DISCUSSION

We appointed counsel to represent defendant on appeal. Counsel filed an opening

brief that sets forth the facts and procedural history of the case and requests this court to

review the record and determine whether there are any arguable issues on appeal.

( People v. Wende

, supra , 25 Cal.3d 436.) Defendant was advised by counsel of the right

to file a supplemental brief within 30 days from the date the opening brief was filed and

has not filed a supplemental brief.

Having undertaken an examination of the entire record pursuant to Wende , we find

no errors that would result in a disposition more favorable to defendant.3 DISPOSITION

The order denying defendant’s petition for resentencing under Penal Code section

1172.6 is affirmed

.

/s/

MESIWALA

, J.

We concur:

/s/ MAURO, Acting P. J.

/s/

KRAUSE , J.
Fourth Court of Appeals

San Antonio, Texas

August 23, 2019

No. 04-19-00097-CV

Laura Zamora BERINGER,

Appellant

v.

Michael BERINGER,

Appellee

From the County Court At Law No 1, Webb County, Texas

Trial Court No. 2017FLB001191C1

Honorable Hugo Martinez, Judge Presiding

ORDER

Appellant’s brief was due on June 24, 2019, but has not been filed. On August 12, 2019, 

the Clerk of Court notified appellant that her brief was late and requested appellant to respond to 

the notice within ten days. On August 20, 2019, appellant responded and filed a motion to 

extend the time to file her brief, requesting a sixty-day extension of the time for filing the brief. 

We GRANT appellant’s motion and extend the deadline for appellant to file her brief to August 

23, 2019. Further requests for extensions of time will be disfavored.

_________________________________

Rebeca C. Martinez, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 23rd day of August, 2019.

___________________________________

KEITH E. HOTTLE,

Clerk of Court
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 2973 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  1st Session
                                S. 2973

To establish an Inspector General of the National Institutes of Health.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 7, 2021

Mrs. Blackburn (for herself, Mr. Hagerty, Mr. Lee, Mr. Tuberville, and 
  Mr. Hawley) introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
To establish an Inspector General of the National Institutes of Health.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ESTABLISHMENT OF INSPECTOR GENERAL OF THE NATIONAL 
              INSTITUTES OF HEALTH.

    (a) Definitions.--Section 12 of the Inspector General Act of 1978 
(5 U.S.C. App.) is amended--
            (1) in paragraph (1), by striking ``or the Director of the 
        National Reconnaissance Office;'' and inserting ``the Director 
        of the National Reconnaissance Office; or the Director of the 
        National Institutes of Health;'' and
            (2) in paragraph (2), by striking ``or the National 
        Reconnaissance Office,'' and inserting ``the National 
        Reconnaissance Office, or the National Institutes of Health,''.
    (b) Appointment of Inspector General.--Not later than 180 days 
after the date of the enactment of this Act, the President shall 
appoint an individual to serve as the Inspector General of the National 
Institutes of Health in accordance with section 3(a) of the Inspector 
General Act of 1978 (5 U.S.C. App.).
                                 <all>
```
EPA# 2979
EPA# 2979
EPA# 2979
EPA# 2979
[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-06698]



[[Page 15621]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; P41 BTRC review (2015/05).
    Date: May 27, 2015.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Manana Sukhareva, Ph.D., Scientific Review 
Officer, National Institute of Biomedical Imaging and 
Bioengineering, 6707 Democracy Boulevard, Suite 959, Bethesda, MD 
20892, (301) 451-3397, <a href="/cdn-cgi/l/email-protection#cdbeb8a6a5acbfa8a08da0aca4a1e3a3a4a5e3aaa2bb"><span class="__cf_email__" data-cfemail="a2d1d7c9cac3d0c7cfe2cfc3cbce8ccccbca8cc5cdd4">[email protected]</span></a>.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; 2015-10 SBIR HD Review.
    Date: June 24, 2015.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual 
Meeting).
    Contact Person: Ruth Grossman, DDS, Scientific Review Officer, 
National Institute of Biomedical Imaging and Bioengineering, 
National Institute of Health, 6707 Democracy Boulevard, Rm. 960, 
Bethesda, MD 20892, (301) 496-8775, <a href="/cdn-cgi/l/email-protection#cbacb9a4b8b8a6aaa5b9b88ba6aaa2a7e5a5a2a3e5aca4bd"><span class="__cf_email__" data-cfemail="2a4d58455959474b4458596a474b434604444342044d455c">[email protected]</span></a>.


    Dated: March 19, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06698 Filed 3-23-15; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
United States Court of Appeals

For the Eighth Circuit

___________________________

No. 16-1804

___________________________

Jamie Lee Jackson

lllllllllllllllllllll Plaintiff - Appellant

v.

Carolyn W. Colvin, Acting Commissioner of Social Security

lllllllllllllllllllll Defendant - Appellee

____________

Appeal from United States District Court 

for the Eastern District of Arkansas - Little Rock

____________

 Submitted: December 2, 2016

 Filed: December 7, 2016

[Unpublished]

____________

Before SMITH, BOWMAN, and BENTON, Circuit Judges. 

____________

PER CURIAM.
Jamie Lee Jackson appeals the district court’s order affirming the

1

Commissioner’s determination thatshe is not entitled to disability insurance benefits,

after her hearing before an administrative law judge. Upon de novo review, see Perks

v. Astrue, 687 F.3d 1086, 1091, 1093 (8th Cir. 2012), we are satisfied that the

decision is supported by substantial evidence on the whole record. The judgment of

the district court is affirmed. See 8th Cir. R. 47B.

______________________________

The Honorable Kristine G. Baker, United States DistrictJudge for the Eastern 1

District of Arkansas, adopting the report and recommendations of the Honorable

Jerome T. Kearney, United States Magistrate Judge for the Eastern District of

Arkansas.

-2-
RODNEY MCCUTCHEON,

Appellant,

v.

FLORIDA COMMISSION ON 

OFFENDER REVIEW,

Appellee.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D14-2098

_____________________________/

Opinion filed October 6, 2014.

An appeal from the Circuit Court for Leon County.

Terry P. Lewis, Judge.

Rodney McCutcheon, pro se, Appellant.

Pamela Jo Bondi, Attorney General, and David W. Grimes, Assistant Attorney 

General, Tallahassee, for Appellee.

PER CURIAM.

AFFIRMED.

VAN NORTWICK, WETHERELL, and MAKAR, JJ., CONCUR.
Exhibit 32

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Simon Property Group, L.P. (the "Company"), on Form 10-K for the period ending
December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



|/S/  DAVID SIMONDavid Simon
Chief Executive Officer
of Simon Property Group, Inc., General Partner
March 16, 2007                                              |  | 
|-------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | 
|/S/  STEPHEN E. STERRETTStephen E. Sterrett
Executive Vice President and Chief Financial Officer of Simon Property Group, Inc., General Partner
March 16, 2007 |  | 

123

---



QuickLinks
# C_2016309EN.01000301.xml

| 25.8.2016 | EN | Official Journal of the European Union | C 309/3 |
| --- | --- | --- | --- |

25.8.2016

EN

Official Journal of the European Union

C 309/3

---

Euro exchange rates (1)

1

24 August 2016

(2016/C 309/04)

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1268 |
| JPY | Japanese yen | 112,95 |
| DKK | Danish krone | 7,4432 |
| GBP | Pound sterling | 0,85130 |
| SEK | Swedish krona | 9,4545 |
| CHF | Swiss franc | 1,0891 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 9,2460 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 27,022 |
| HUF | Hungarian forint | 309,99 |
| PLN | Polish zloty | 4,3039 |
| RON | Romanian leu | 4,4597 |
| TRY | Turkish lira | 3,3290 |
| AUD | Australian dollar | 1,4782 |
| CAD | Canadian dollar | 1,4581 |
| HKD | Hong Kong dollar | 8,7370 |
| NZD | New Zealand dollar | 1,5400 |
| SGD | Singapore dollar | 1,5257 |
| KRW | South Korean won | 1 264,96 |
| ZAR | South African rand | 15,9380 |
| CNY | Chinese yuan renminbi | 7,5013 |
| HRK | Croatian kuna | 7,4920 |
| IDR | Indonesian rupiah | 14 969,54 |
| MYR | Malaysian ringgit | 4,5537 |
| PHP | Philippine peso | 52,396 |
| RUB | Russian rouble | 73,0561 |
| THB | Thai baht | 39,013 |
| BRL | Brazilian real | 3,6463 |
| MXN | Mexican peso | 20,8945 |
| INR | Indian rupee | 75,6268 |

Currency

Exchange rate

USD

US dollar

1,1268

JPY

Japanese yen

112,95

DKK

Danish krone

7,4432

GBP

Pound sterling

0,85130

SEK

Swedish krona

9,4545

CHF

Swiss franc

1,0891

ISK

Iceland króna

NOK

Norwegian krone

9,2460

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

27,022

HUF

Hungarian forint

309,99

PLN

Polish zloty

4,3039

RON

Romanian leu

4,4597

TRY

Turkish lira

3,3290

AUD

Australian dollar

1,4782

CAD

Canadian dollar

1,4581

HKD

Hong Kong dollar

8,7370

NZD

New Zealand dollar

1,5400

SGD

Singapore dollar

1,5257

KRW

South Korean won

1 264,96

ZAR

South African rand

15,9380

CNY

Chinese yuan renminbi

7,5013

HRK

Croatian kuna

7,4920

IDR

Indonesian rupiah

14 969,54

MYR

Malaysian ringgit

4,5537

PHP

Philippine peso

52,396

RUB

Russian rouble

73,0561

THB

Thai baht

39,013

BRL

Brazilian real

3,6463

MXN

Mexican peso

20,8945

INR

Indian rupee

75,6268

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
EXHIBIT 32




Certification of the Chief Executive Officer and Chief Financial Officer


Pursuant to 18 U.S.C. §1350,


as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002




In connection with the Amendment No. 1 to Annual Report of Tesco Corporation (the “Company”) on Form 10-K/A for the year ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Julio M. Quintana, as President and Chief Executive Officer of the Company, and Robert L. Kayl, as Senior Vice President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:




(1) The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and




(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date: May  2, 2011
/s/ Julio M. QuintanaJulio M. QuintanaPresident and Chief Executive OfficerDate: May  2, 2011
/s/ Robert L. KaylRobert L. KaylSenior Vice President and Chief Financial Officer







The foregoing certification shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.
# C_2016273EN.01000702.xml

| 27.7.2016 | EN | Official Journal of the European Union | C 273/7 |
| --- | --- | --- | --- |

27.7.2016

EN

Official Journal of the European Union

C 273/7

---

Non-opposition to a notified concentration

(Case M.7986 — Sysco/Brakes)

(Text with EEA relevance)

(2016/C 273/03)

On 9 June 2016, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in the English language and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32016M7986. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32016M7986. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
[Federal Register Volume 80, Number 62 (Wednesday, April 1, 2015)]
[Notices]
[Page 17442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-07342]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Board of Scientific Counselors, National Advisory Neurological 
Disorders and Stroke.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(6), Title 
5 U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Neurological Disorders and Stroke, including consideration 
of personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Institute of Neurological Disorders and Stroke.
    Date: May 17-19, 2015.
    Time: 7:00 p.m. to 10:30 a.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Alan P. Koretsky, Ph.D., Scientific Director, 
Division of Intramural Research, National Institute of Neurological 
Disorders and Stroke, NIH, 35 Convent Drive, Room 6A908, Bethesda, 
MD 20892, (301) 435-2232, <a href="/cdn-cgi/l/email-protection#d3b8bca1b6a7a0b8aab293bdbabdb7a0fdbdbabbfdb4bca5"><span class="__cf_email__" data-cfemail="e18a8e938495928a9880a18f888f8592cf8f8889cf868e97">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS).

    Dated: March 26, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-07342 Filed 3-31-15; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit
13.1




CARTHEW
BAY TECHNOLOGIES INC.




CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Annual Report of Carthew Bay Technologies Inc. (the
“Company”) on Form 20-F for the period ending December 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Michael Liik, President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:




(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.




/s/
      Michael LiikMichael
      LiikPresident
      and Chief Executive OfficerSeptember
      15, 2010
### THE THIRTEENTH COURT OF APPEALS

13

- 13

- 00679

- CR

RENE ZAMORA v. THE STATE OF TEXAS
On Appeal from the 331st District Court of Travis County , Texas Trial Cause No. D

- 1

- DC

- 13

- 904011

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered this caus e on appeal, concludes that the judgment of the trial court should be AFFIRMED . The Court orders the judgment of the trial court AFFIRMED

. We further order this decision certified below for observance. July 2, 2015